🇺🇸 FDA
Patent

US 11013809

Sustained delivery formulations of risperidone compound

granted A61KA61K31/519A61K47/22

Quick answer

US patent 11013809 (Sustained delivery formulations of risperidone compound) held by Indivior UK Limited expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Indivior UK Limited
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/519, A61K47/22, A61K47/32, A61K47/34